Nabriva Therapeutics PLC - ADR (NBRV) stock is higher by 95.36% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 34 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. NBRV's rank also includes a long-term technical score of 1. The fundamental score for NBRV is 99. In addition to the average rating from Wall Street analysts, NBRV stock has a mean target price of 2. This means analysts expect the stock to fall 47.23% over the next 12 months.
What's Happening with NBRV Stock Today
Nabriva Therapeutics PLC - ADR (NBRV) stock has fallen -3.88% while the S&P 500 is higher by 0.08% as of 9:47 AM on Thursday, Dec 3. NBRV is lower by -$0.15 from the previous closing price of $3.94 on volume of 60,273 shares. Over the past year the S&P 500 is up 17.96% while NBRV is higher by 95.36%. NBRV lost -$0.76 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Nabriva Therapeutics PLC - ADR (NBRV) Stock.